Velaritas Holdings Reports Positive Data for Wearable Insulin Device for Type 2 Diabetes Patients
New Jersey-based medical technology company Velaritas Holdings (NASDAQ:VLRX) reported positive results from two of its clinical studies, on Friday. The studies were focused on the company’s wearable insulin device, V-Go, for patients with Type 2 Diabetes. The first ... [Read]
Valeritas Announces Release of V-Go Product in Australia and NZ
Medical technology company Valeritas (NASDAQ:VLRX) has today announced that it is to release its V-Go wearable insulin delivery device in Australia and New Zealand. Stocks in the firm have skyrocketed 96.3% on the news, making ... [Read]